J P Bourquin - JoVE Visualize

Showing results (1-10 of 17) with videos related to

Pageof 2

Sort By:

Biological Chemistry|June 1, 1997

A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domainS Tanner, I Stagljar, O Georgiev, et al.

Nucleic Acids Research|December 15, 1996

Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1P Moosmann, O Georgiev, B Le Douarin, et al.

Biological Chemistry|February 14, 1998

Long non-stop reading frames on the antisense strand of heat shock protein 70 genes and prion protein (PrP) genes are conserved between speciesK I Rother, O K Clay, J P Bourquin, et al.

Gene|February 12, 1996

Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteinsO Georgiev, J P Bourquin, M Gstaiger, et al.

Nucleic Acids Research|June 1, 1997

A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase IIJ P Bourquin, I Stagljar, P Meier, et al.

Pediatric Hematology and Oncology|February 7, 2014

Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old childNathalie Rock, V Mattiello, C Judas, et al.

Bone Marrow Transplantation|September 9, 2004

Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhoodJ P Bourquin, I Thornley, D Neuberg, et al.

Nucleic Acids Research|July 22, 1998

SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elementsO Nayler, W Strätling, J P Bourquin, et al.

Klinische Padiatrie|May 19, 2015

Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004U Creutzig, M Dworzak, M Zimmermann, et al.

Leukemia|October 5, 2011

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group reportU Creutzig, M Zimmermann, J-P Bourquin, et al.

Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:

Pageof 2

Biological Chemistry|June 1, 1997

A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domainS Tanner, I Stagljar, O Georgiev, et al.

Nucleic Acids Research|December 15, 1996

Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1P Moosmann, O Georgiev, B Le Douarin, et al.

Biological Chemistry|February 14, 1998

Long non-stop reading frames on the antisense strand of heat shock protein 70 genes and prion protein (PrP) genes are conserved between speciesK I Rother, O K Clay, J P Bourquin, et al.

Gene|February 12, 1996

Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteinsO Georgiev, J P Bourquin, M Gstaiger, et al.

Nucleic Acids Research|June 1, 1997

A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase IIJ P Bourquin, I Stagljar, P Meier, et al.

Pediatric Hematology and Oncology|February 7, 2014

Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old childNathalie Rock, V Mattiello, C Judas, et al.

Bone Marrow Transplantation|September 9, 2004

Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhoodJ P Bourquin, I Thornley, D Neuberg, et al.

Nucleic Acids Research|July 22, 1998

SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elementsO Nayler, W Strätling, J P Bourquin, et al.

Klinische Padiatrie|May 19, 2015

Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004U Creutzig, M Dworzak, M Zimmermann, et al.

Leukemia|October 5, 2011

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group reportU Creutzig, M Zimmermann, J-P Bourquin, et al.

Pageof 2